| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4188849 | Psiquiatría Biológica | 2006 | 7 Pages |
Abstract
Omega-3 polyunsaturated fatty acids play a major role in the correct functioning of the neuronal membrane. Numerous studies suggest that the consumption of omega-3 fatty acid supplements (especially eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) could produce a clinical improvement in some neuropsychiatric disorders. This article presents an updated review of the evidence available on the use of these compounds in the treatment of schizophrenia, depression, bipolar disorder, and other neuropsychiatric abnormalities.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
José Francisco Navarro, MarÃa Cavas, Francisca B. GarcÃa,